🇨🇦 patients with sunitinib or pazopanib in Canada

patients with sunitinib or pazopanib (patients with sunitinib or pazopanib) regulatory status in Canada.

Marketing authorisation

patients with sunitinib or pazopanib in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is patients with sunitinib or pazopanib approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for patients with sunitinib or pazopanib in Canada?

Cliniques universitaires Saint-Luc- Université Catholique de Louvain is the originator. The local marketing authorisation holder may differ — check the official source linked above.